Moreover, the recent observation that EZH2 may act as a tumor suppressor in certain hematologic disorders [14], [15], [16] suggests that EZH2 inhibition could even promote tumorigenesis, in some tissues. The gene discussed is EZH2; the disease is hematologic disorder.